NO750005L - - Google Patents
Info
- Publication number
- NO750005L NO750005L NO750005A NO750005A NO750005L NO 750005 L NO750005 L NO 750005L NO 750005 A NO750005 A NO 750005A NO 750005 A NO750005 A NO 750005A NO 750005 L NO750005 L NO 750005L
- Authority
- NO
- Norway
- Prior art keywords
- acid
- water
- ester
- mandelic acid
- organic solvent
- Prior art date
Links
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 claims description 14
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 claims description 13
- 229960002510 mandelic acid Drugs 0.000 claims description 13
- 150000002148 esters Chemical class 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 9
- -1 3,3,5-trimethylcyclohexyl ester Chemical class 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 7
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 5
- AWUNQYSCRNDEPS-UHFFFAOYSA-N 2-phenyl-2-(pyridine-3-carbonyloxy)acetic acid Chemical compound C=1C=CC=CC=1C(C(=O)O)OC(=O)C1=CC=CN=C1 AWUNQYSCRNDEPS-UHFFFAOYSA-N 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- MSYBLBLAMDYKKZ-UHFFFAOYSA-N hydron;pyridine-3-carbonyl chloride;chloride Chemical compound Cl.ClC(=O)C1=CC=CN=C1 MSYBLBLAMDYKKZ-UHFFFAOYSA-N 0.000 claims description 2
- ATBIAJXSKNPHEI-UHFFFAOYSA-N pyridine-3-carbonyl chloride Chemical compound ClC(=O)C1=CC=CN=C1 ATBIAJXSKNPHEI-UHFFFAOYSA-N 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 7
- 230000002048 spasmolytic effect Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- 229960000583 acetic acid Drugs 0.000 description 4
- 239000000812 cholinergic antagonist Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 206010022998 Irritability Diseases 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- UOTMYNBWXDUBNX-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinolin-2-ium;chloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 UOTMYNBWXDUBNX-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000786363 Rhampholeon spectrum Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- YDVNLQGCLLPHAH-UHFFFAOYSA-N dichloromethane;hydrate Chemical compound O.ClCCl YDVNLQGCLLPHAH-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012738 dissolution medium Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH2274 | 1974-01-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO750005L true NO750005L (en:Method) | 1975-07-28 |
Family
ID=4177599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO750005A NO750005L (en:Method) | 1974-01-03 | 1975-01-02 |
Country Status (10)
| Country | Link |
|---|---|
| JP (1) | JPS50105670A (en:Method) |
| BE (1) | BE824034A (en:Method) |
| DE (1) | DE2461909A1 (en:Method) |
| DK (1) | DK678174A (en:Method) |
| ES (1) | ES433493A1 (en:Method) |
| FI (1) | FI378374A7 (en:Method) |
| FR (1) | FR2256757A1 (en:Method) |
| NL (1) | NL7500065A (en:Method) |
| NO (1) | NO750005L (en:Method) |
| SE (1) | SE7416232L (en:Method) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1175810B (it) * | 1984-03-07 | 1987-07-15 | Ravizza Spa | Processo per la preparazione di cis-3,3,5-trimetilcicloesil-d,l-(3-piridin-carbossi)-fenilacetato |
-
1974
- 1974-12-23 DK DK678174A patent/DK678174A/da unknown
- 1974-12-23 SE SE7416232A patent/SE7416232L/xx unknown
- 1974-12-28 JP JP50004187A patent/JPS50105670A/ja active Pending
- 1974-12-30 FI FI3783/74A patent/FI378374A7/fi unknown
- 1974-12-31 DE DE19742461909 patent/DE2461909A1/de active Pending
- 1974-12-31 BE BE152086A patent/BE824034A/xx unknown
-
1975
- 1975-01-02 ES ES433493A patent/ES433493A1/es not_active Expired
- 1975-01-02 NO NO750005A patent/NO750005L/no unknown
- 1975-01-03 FR FR7500119A patent/FR2256757A1/fr not_active Withdrawn
- 1975-01-03 NL NL7500065A patent/NL7500065A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE2461909A1 (de) | 1975-07-17 |
| BE824034A (fr) | 1975-04-16 |
| DK678174A (en:Method) | 1975-09-01 |
| ES433493A1 (es) | 1976-12-01 |
| FI378374A7 (en:Method) | 1975-07-04 |
| JPS50105670A (en:Method) | 1975-08-20 |
| SE7416232L (en:Method) | 1975-07-04 |
| NL7500065A (nl) | 1975-07-07 |
| FR2256757A1 (en) | 1975-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO163083B (no) | Hoeyabsorberende, naeringsfattig tilsetnings- og fyllmiddelfor kostfiberprodukter, basert paa vekstfibre. | |
| NO142441B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk virksomme karboksylsyrederivater | |
| Clark | Quassin. I. The preparation and purification of quassin and neoquassin, with information concerning their molecular formulas | |
| Clarke et al. | Studies of crystalline vitamin B1. XII. The sulfur-containing moiety | |
| Calam et al. | The potato eelworm hatching factor. 2. Purification of the factor by alkaloid salt fractionation. Anhydrotetronic acid as an artificial hatching agent | |
| O'Dwyer | The hemicelluloses. III. The hemicellulose of American white oak | |
| NO750005L (en:Method) | ||
| Cao et al. | A fluorescent probe for visualizing peroxynitrite levels during plant growth under abiotic stresses | |
| Barger | CXXIII.—Saponarin, a new glucoside, coloured blue with iodine | |
| US3585214A (en) | Hydroxyl derivatives of coumarine and processes for the preparation thereof | |
| Smith et al. | 311. The alkaloids of ergot. Part VII. iso Ergine and iso lysergic acids | |
| Power et al. | XXIII.—The constituents of the rhizome and roots of Caulophyllum thalictroides | |
| NO167807B (no) | Analogifremgangsmaate til fremstilling av 3',4'-dinitrogensubstituerte epipodofyllotoksinglukosidderivater. | |
| Stewart | Recent advances in organic chemistry | |
| Hudson et al. | The Optical Rotatory Powers of Some Acetylated Derivatives of Maltose, Cellose and Lactose. | |
| Michel | Growth responses of crucifers to indoleacetic acid and indoleacetonitrile | |
| Fairbairn et al. | The alkaloids of hemlock (Conium maculatum L.)—III: The presence of bound forms in the plant | |
| Power et al. | CCXXVI.—The constituents of the seeds of Casimiroa edulis | |
| Thurston et al. | Asymmetric syntheses. IV. The action of optically active nitrates on 2-bromo-fluorene | |
| Henry et al. | CCLIV.—the alkaloids of Picralima klaineana | |
| AU594686B2 (en) | Process for the preparation of 2-halonicergoline derivatives and their acid addition salts and new 2-halonicergolines | |
| Parihar et al. | Chemical examination of the bark of Alangium Lamarkii Thwaites. Isolation of the alkaloid alangine | |
| Gordin | MARRUBIIN. | |
| SHIBATA et al. | Daphniphillin, a new anthocyanin isolated from the pericarp of Daphniphyllium macropodum | |
| Pyman | CXIII.—Calmatambin: a new glucoside |